3D Systems Posts Q2 2025 Results: $95M Revenue, $104.4M Net Income, $20M Cost Savings
ByAinvest
Wednesday, Aug 13, 2025 11:08 am ET1min read
DDD--
Despite a 16% decrease in revenue compared to the same period last year, 3D Systems saw a 38.1% gross profit margin, up from 41.6% a year earlier. The company attributed this to cost reduction strategies, which saved over $20 million, and a successful balance sheet restructuring, including retiring $88 million in debt. These efforts resulted in a positive net income of $104.4 million for the quarter.
The Medical Technology sector, particularly Personal Health Services, grew by 13% year-over-year and 16% sequentially. The Aerospace & Defense market also performed well, with revenues increasing by 84% year-over-year and 53% sequentially, driven by strong demand for high-reliability components.
3D Systems' Regenerative Medicine partnership with United Therapeutics reached a new printing milestone, earning a $2 million award. Additionally, the company repurchased 8 million shares and retired $88 million in debt as part of its balance sheet restructuring, aimed at enhancing shareholder value.
Looking ahead, 3D Systems anticipates continued challenges from tariffs but remains optimistic about future revenue growth and restructuring efforts aimed at returning to positive cash flow by 2026.
References:
[1] https://www.quiverquant.com/news/3D+Systems+Corporation+Reports+Q2+2025+Financial+Results+with+%2495+Million+in+Revenue+and+Significant+Profit+Improvement
3D Systems Corp reported Q2 2025 financial results with a revenue of $95 million, driven by growth in Medical Technology and Aerospace & Defense markets. The company achieved a milestone in its Regenerative Medicine partnership and saw significant cost savings, leading to a positive net income of $104.4 million. Despite a 16% year-over-year revenue decline, the company is optimistic about its growth prospects, particularly in high-reliability markets like Aerospace & Defense.
3D Systems Corporation (NYSE: DDD) reported its second-quarter (Q2) 2025 financial results, revealing a revenue of $94.8 million, a 16% decline year-over-year, but achieving a significant net income of $104.4 million. The company's performance was driven by growth in the Medical Technology and Aerospace & Defense markets, as well as a milestone in its Regenerative Medicine partnership.Despite a 16% decrease in revenue compared to the same period last year, 3D Systems saw a 38.1% gross profit margin, up from 41.6% a year earlier. The company attributed this to cost reduction strategies, which saved over $20 million, and a successful balance sheet restructuring, including retiring $88 million in debt. These efforts resulted in a positive net income of $104.4 million for the quarter.
The Medical Technology sector, particularly Personal Health Services, grew by 13% year-over-year and 16% sequentially. The Aerospace & Defense market also performed well, with revenues increasing by 84% year-over-year and 53% sequentially, driven by strong demand for high-reliability components.
3D Systems' Regenerative Medicine partnership with United Therapeutics reached a new printing milestone, earning a $2 million award. Additionally, the company repurchased 8 million shares and retired $88 million in debt as part of its balance sheet restructuring, aimed at enhancing shareholder value.
Looking ahead, 3D Systems anticipates continued challenges from tariffs but remains optimistic about future revenue growth and restructuring efforts aimed at returning to positive cash flow by 2026.
References:
[1] https://www.quiverquant.com/news/3D+Systems+Corporation+Reports+Q2+2025+Financial+Results+with+%2495+Million+in+Revenue+and+Significant+Profit+Improvement

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet